Literature DB >> 30499185

CrossTalk opposing view: The mouse SuHx model is not a good model of pulmonary arterial hypertension.

Sally H Vitali1.   

Abstract

Entities:  

Keywords:  Sugen 5416; animal models; chronic hypoxia; pulmonary hypertension; right ventricle

Mesh：

Substances：

Year:  2018        PMID： 30499185      PMCID： PMC6375861          DOI： 10.1113/JP275865

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  26 in total

1.  Usefulness of a mouse model of reversible pulmonary arterial hypertension: be cautious, choose carefully.

Authors:  José Gomez-Arroyo; Norbert F Voelkel; Harm J Bogaard; Laima Taraseviciene-Stewart
Journal:  Am J Respir Crit Care Med       Date:  2012-06-15       Impact factor: 21.405

2.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Authors:  L Taraseviciene-Stewart; Y Kasahara; L Alger; P Hirth; G Mc Mahon ; J Waltenberger; N F Voelkel; R M Tuder
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

3.  Functional magnetic resonance imaging for in vivo quantification of pulmonary hypertension in the Sugen 5416/hypoxia mouse.

Authors:  Ellen C Breen; Miriam Scadeng; N Chin Lai; Fiona Murray; Timothy D Bigby
Journal:  Exp Physiol       Date:  2017-02-14       Impact factor: 2.969

Review 4.  Molecular pathogenesis and current pathology of pulmonary hypertension.

Authors:  Vinicio A de Jesus Perez
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

5.  Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.

Authors:  Toshio Suzuki; Erica J Carrier; Megha H Talati; Anandharajan Rathinasabapathy; Xinping Chen; Rintaro Nishimura; Yuji Tada; Koichiro Tatsumi; James West
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-21       Impact factor: 5.464

6.  Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.

Authors:  Andrea L Frump; Kara N Goss; Alexandra Vayl; Marjorie Albrecht; Amanda Fisher; Roziya Tursunova; John Fierst; Jordan Whitson; Anthony R Cucci; M Beth Brown; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

Review 7.  The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

8.  Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.

Authors:  Mario Boehm; Nadine Arnold; Adam Braithwaite; Josephine Pickworth; Changwu Lu; Tatyana Novoyatleva; David G Kiely; Friedrich Grimminger; Hossein A Ghofrani; Norbert Weissmann; Werner Seeger; Allan Lawrie; Ralph T Schermuly; Baktybek Kojonazarov
Journal:  BMC Pulm Med       Date:  2018-03-02       Impact factor: 3.320

9.  Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.

Authors:  Loredana Ciuclan; Kellyann Sheppard; Liqun Dong; Daniel Sutton; Nicholas Duggan; Martin Hussey; Jenny Simmons; Nicholas W Morrell; Gabor Jarai; Matthew Edwards; Gerald Dubois; Matthew Thomas; Gino Van Heeke; Karen England
Journal:  Am J Pathol       Date:  2013-11       Impact factor: 4.307

10.  Limiting collagen turnover via collagenase-resistance attenuates right ventricular dysfunction and fibrosis in pulmonary arterial hypertension.

Authors:  Mark J Golob; Zhijie Wang; Anthony J Prostrollo; Timothy A Hacker; Naomi C Chesler
Journal:  Physiol Rep       Date:  2016-06
View more
  2 in total

1.  Overview: pulmonary vascular function in health and disease.

Authors:  Larissa A Shimoda
Journal:  J Physiol       Date:  2019-02       Impact factor: 5.182

2.  Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension.

Authors:  Anna Krzyżewska; Marta Baranowska-Kuczko; Anna Jastrząb; Irena Kasacka; Hanna Kozłowska
Journal:  Molecules       Date:  2022-05-22       Impact factor: 4.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.